Renaissance Group LLC Boosts Stake in HealthEquity, Inc. $HQY

Renaissance Group LLC grew its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 8.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 80,494 shares of the company’s stock after acquiring an additional 6,539 shares during the quarter. Renaissance Group LLC’s holdings in HealthEquity were worth $7,628,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Axim Planning & Wealth purchased a new stake in shares of HealthEquity during the 3rd quarter worth about $248,000. Homestead Advisers Corp raised its holdings in HealthEquity by 21.9% in the third quarter. Homestead Advisers Corp now owns 32,800 shares of the company’s stock valued at $3,108,000 after buying an additional 5,900 shares during the period. Bessemer Group Inc. lifted its position in HealthEquity by 21.3% during the third quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock valued at $33,108,000 after buying an additional 61,317 shares in the last quarter. Optimize Financial Inc purchased a new stake in HealthEquity during the third quarter worth approximately $440,000. Finally, Savant Capital LLC purchased a new stake in HealthEquity during the third quarter worth approximately $383,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. The Goldman Sachs Group downgraded shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price on the stock. in a research note on Friday, January 9th. Citigroup reissued an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Citizens Jmp boosted their price objective on HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a research note on Thursday, December 4th. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Finally, Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Monday, January 19th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and an average target price of $119.60.

Insider Buying and Selling

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This represents a 1.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares of the company’s stock, valued at $4,366,073.90. The trade was a 19.33% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 13,959 shares of company stock worth $1,344,957. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Stock Up 0.3%

Shares of HealthEquity stock opened at $79.45 on Friday. The business has a 50-day moving average of $90.56 and a 200-day moving average of $92.98. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The company has a market capitalization of $6.79 billion, a PE ratio of 36.44, a P/E/G ratio of 0.99 and a beta of 0.24. HealthEquity, Inc. has a 1-year low of $74.07 and a 1-year high of $116.65.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.90 by $0.11. The business had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The company’s revenue was up 7.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.